Post-earnings recap
Reported
Wed, Feb 6, 2019
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
Boston Scientific's earnings report showed a positive surprise in EPS, which contributed to a 2.7% increase in stock price. The management's focus on innovation suggests they are looking to strengthen their market position, even without specific guidance for the future. Investors may view the EPS beat as a sign of underlying strength in the company's operations.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.39 | N/A | +2.93% |
Management expressed satisfaction with the EPS results, highlighting their commitment to innovation. However, they did not provide specific guidance for future quarters.
We are pleased with our EPS performance this quarter.
Our focus remains on innovation and expanding our market presence.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—